share_log

China Medical System Holdings Insider Ups Holding During Year

China Medical System Holdings Insider Ups Holding During Year

中国医疗系统控股在一年内增加持股
Simply Wall St ·  12/02 20:30

From what we can see, insiders were net buyers in China Medical System Holdings Limited's (HKG:867 ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.

从我们所看到的情况来看,中国医药系统控股有限公司(HKG:867)的内部人士在过去12个月中是净买家。也就是说,内部人士购入该股票的数量大于卖出数量。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

尽管我们永远不会建议投资者仅基于公司董事的行动做出决策,但逻辑推断您应该关注内部人士是否买卖股票。

China Medical System Holdings Insider Transactions Over The Last Year

中国医药系统控股过去一年的内部交易情况

In the last twelve months, the biggest single purchase by an insider was when Founder Kong Lam bought HK$7.3m worth of shares at a price of HK$7.32 per share. That means that an insider was happy to buy shares at around the current price of HK$7.78. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for China Medical System Holdings share holders is that an insider was buying at near the current price. Kong Lam was the only individual insider to buy shares in the last twelve months.

在过去的十二个月中,内部人士最大的单笔购买是创始人孔岚以每股7.32港元的价格购入价值730万港元的股份。这意味着某位内部人士乐意以大致当前7.78港元的价格购入股票。当然,他们可能改变主意。但这表明他们是乐观的。如果有人以远低于现价的价格购入股票,总体上这是一个好迹象,但请记得他们可能不再看到价值。对于中国医药系统控股的股东来说,一个内部人士以接近当前价格购买是个好消息。孔岚是过去一年唯一一位个人内部买家。

Kong Lam purchased 30.00m shares over the year. The average price per share was HK$7.14. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

孔岚在过去一年内购入了3000万股。每股的平均价格为7.14港元。您可以在下方图表中查看过去一年公司和个人的内部交易情况。如果您点击图表,您可以看到所有的个别交易,包括股价、个人和日期!

big
SEHK:867 Insider Trading Volume December 3rd 2024
SEHK:867 内幕交易 成交量 2024年12月3日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

还有很多其他的公司,公司的内部人士正在购买股票。你可能不想错过这个免费的小市值公司的低估列表。

Insider Ownership Of China Medical System Holdings

中国医疗系统控股股权内幕

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. China Medical System Holdings insiders own about HK$9.7b worth of shares (which is 52% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

另一种测试公司领导人与其他股东之间对齐程度的方法是看他们拥有多少股份。我们通常喜欢看到相当高比例的内部持股。中国医疗系统控股内部人持有价值约97亿港元的股份(占公司的52%)。大多数股东会乐见这种内部人持股比例,因为这表明管理层的激励与其他股东保持良好对齐。

So What Does This Data Suggest About China Medical System Holdings Insiders?

那么这些数据对中国医疗系统控股内部人有何建议?

It's certainly positive to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest China Medical System Holdings insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we found 2 warning signs for China Medical System Holdings that deserve your attention before buying any shares.

最近看到内部人购买肯定是积极的。过去一年交易的分析也让我们信心满满。当结合显著的内部持股时,这些因素表明中国医疗系统控股内部人对齐度很高,而且很可能认为股价太低。至少应将其列入自选之一!虽然了解内部人的持股和交易情况很重要,但在做出任何投资决定之前,我们还会考虑股票面临的风险。在Simply Wall St,我们发现中国医疗系统控股存在两个警示信号,值得在购买任何股份之前引起您的关注。

Of course China Medical System Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,中国医疗系统控股可能不是最佳买入股票。因此,您可能希望查看这些优质公司的免费合集。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发